Finland· FI-REL-REL26832
Glucosamin Orifarm
A glucosamine product containing glucosamine sulfate sodium chloride, registered in Finland by Orifarm Generics A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Glucosamine is registered in 14 of 19 countries.
Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Glucosamine · ATC M01AX05
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
Price per daily dose
What a daily dose of glucosamine costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Glucosamine · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$0.23
The record
At a glance
Fimea (Finland)- Active substance
- Glucosamine sulfate sodium chloride
- Manufacturer
- Orifarm Generics A/S
- Country
- Finland (FI)
- ATC code
- M01AX05
- ATC class
- Glucosamine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for glucosamine.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucosamine · interactions on record
2 records
- 2 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glucosamine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDONAMylan IRE Healthcare Limited, Dublin
- BelgiumGlucosamine Trenker 1500 mgLaboratoires Pharmaceutiques Trenker - Pharmaceutische Laborator
- GermanyDolexBlue Bio Pharmaceuticals Ltd
- NorwayDonacom2care4 ApS
- SwedenDolenio 1178 mg Filmdragerad tablettBlue Bio Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Tavimin
- Belgium · Dolenio, Donacom
- Bulgaria · Артрон А, Бонартос
- Cyprus · Dolenio
- Czechia · Bayflex, Dona
- Germany · Dolex, Dona
- Denmark · Dolenio, Glucofarm Once
- Estonia · Dolenio, Glucosamin Ratiopharm
- Spain · Cartisorb, Coderol
- France · Dolenio
- United Kingdom (Northern Ireland) · Dolenio, Glucosamine Sulphate
- Greece · Dolenio, Glucasulf
- Croatia · Arthryl
- Hungary · Arthryl, Atrofort
- Ireland · Arthrimel, Dolenio
- Iceland · Dolenio
- Italy · Dona, Glucosamina Solfato Doc Generici
- Lithuania · Arthryl, Glucosamin Ratiopharm
- Luxembourg · Dolenio
- Latvia · Arthryl, Glucosamin Ratiopharm
- Malta · Dolenio
- Netherlands · Dolenio
- Poland · Arthryl, Slideflex
- Portugal · Cartilon, Dolenio
- Romania · Slideflex
- Slovenia · Fidiflex
- Slovakia · Dona
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/052bd332-f36a-4873-8a98-8db4a081f19b GET /v1/drugs/052bd332-f36a-4873-8a98-8db4a081f19b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1.5",
"form": "jauhe oraaliliuosta varten",
"route": "Suun kautta",
"ddd_unit": "g",
"strength": "1.5 g",
"atc_label": "glukosamiini",
"ma_number": "22503",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL26832",
"authorised_at": "2008-10-30"
}See everything about glucosamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.